Pharmacology of the endometrium.
D000305:Adrenal Cortex Hormones / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D000328:Adult; D000728:Androgens / Q000627:therapeutic use; D000818:Animals; D001665:Binding Sites; D001682:Biological Availability; D003338:Corpus Luteum / Q000502:physiology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004344:Drug Incompatibility; D004717:Endometrium / Q000187:drug effects*; D004965:Estrogen Antagonists; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011372:Progestins / Q000145:classification / Q000627:therapeutic use; D011817:Rabbits; D011956:Receptors, Cell Surface; D013045:Species Specificity; D014594:Uterine Neoplasms / Q000139:chemically induced / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D000728:Androgens; D004965:Estrogen Antagonists; D004967:Estrogens; D011372:Progestins; D011956:Receptors, Cell Surface